Acute Effects of Cycling Dual-task in Parkinson´s Disease.

May 24, 2023 updated by: Iris Machado de Oliveira, University of Vigo

Acute Effects of Cycling Dual-task on Cognitive and Physical Function in Parkinson´s Disease: a Cross-sectional Study.

Taking into account the process of functional and cognitive evolution that patients with Parkinson's disease experience throughout the pathology, the objective of this study is to evaluate the acute effects of aerobic exercise in forced cycling performed with lower limbs and freecycling of upper limbs combined with cognitive stimuli on attention, exploration skills, and short-term motor skills in people with Parkinson's disease.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

44

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Pontevedra, Spain, 36004
        • University of Vigo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Idiopathic Parkinson's disease
  • Present stage between I and III on the Hoenh and Yarh scale
  • Being able to move autonomously

Exclusion Criteria:

  • Moderate-severe cognitive impairment (Mini-mental test > 24)
  • Comorbidity that discourages the practice of physical exercise and that allows performing all scheduled assessments
  • Severe visual alterations that prevent the development of the session

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Cycling combined with cognitive tasks
A 30-minute session of Forced Cycling aerobic exercise performed with lower limbs and free active cycling performed with upper limbs combined with cognitive stimuli. An intelligent cycle ergometer (Motomed Viva 2 Parkinson) will be used, at a reserve heart rate of 55-70% (Borg scale 12-14) during the active part. The forced cycling program will consist of a 6-minute passive warm-up part (40-60 RPM), a 20-minute active part (90 RPM), and a 4-minute passive cool down (40 RPM). The cognitive task will be a PowerPoint presentation structured in a way that is consistent with the phases of the cycling program. The passive phases (6 minutes of warm-up and 4 minutes of passive cycling back to cool down), images of the nearby environment will be played. For the active phase (20 minutes of assisted active cycling) the PowerPoint presentation will be structured with tasks related to: orientation, memory, calculation, language, similarities.
Other Names:
  • Cycling dual task
Active Comparator: Cycling
A 30-minute session of Forced Cycling aerobic exercise performed with lower limbs and free active cycling performed with upper limbs combined with cognitive stimuli. An intelligent cycle ergometer (Motomed Viva 2 Parkinson) will be used, at a reserve heart rate of 55-70% (Borg scale 12-14) during the active part. The forced cycling program will consist of a 6-minute passive warm-up part (40-60 RPM), a 20-minute active part (90 RPM), and a 4-minute passive cool down (40 RPM).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline Heart Rate at 30 minutes
Time Frame: Pre and up to 30 minutes.
Heart rate
Pre and up to 30 minutes.
Change from baseline Symbol Digit Modalities Test at 30 minutes
Time Frame: Pre and up to 30 minutes.
Detection of cognitive dysfuntions.
Pre and up to 30 minutes.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Borg Rated Perceived Exertion Scale
Time Frame: Up to 30 minutes.
Perceived exertion. These include a rating of 6 perceiving "no exertion at all" to 20 perceiving a "maximal exertion" of effort.
Up to 30 minutes.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Active Distance (m)
Time Frame: During the unique session
Cycling active distance in meters.
During the unique session
Passive Distance (m)
Time Frame: During the unique session
Cycling assisted distance in meters.
During the unique session
Total Work (W)
Time Frame: During the unique session
Cycling total work developed in Watts
During the unique session
Active Speed (rpm)
Time Frame: During the unique session
Average cycling active speed in rotation per minute
During the unique session
Passive Speed (rpm)
Time Frame: During the unique session
Average cycling assisted speed in rotation per minute
During the unique session
Symmetry (%)
Time Frame: During the unique session
Percentage of the active work developed by each lower limb, right and left.
During the unique session

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 13, 2022

Primary Completion (Actual)

July 31, 2022

Study Completion (Actual)

December 15, 2022

Study Registration Dates

First Submitted

May 2, 2022

First Submitted That Met QC Criteria

May 13, 2022

First Posted (Actual)

May 16, 2022

Study Record Updates

Last Update Posted (Actual)

May 25, 2023

Last Update Submitted That Met QC Criteria

May 24, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parkinson Disease

Clinical Trials on Cycling combined with cognitive tasks

3
Subscribe